CLINICAL_TRIALS
trial_result
· 2019-01-30
Clinical Trial Update: Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes [Phase 2]
Summary
Phase 2 clinical trial investigating verapamil as a therapy to improve beta cell survival in type 1 diabetes completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2019-01-30